LONZA GRP AG/ADR (OTCMKTS:LZAGY) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Wednesday.

Separately, Zacks Investment Research upgraded shares of LONZA GRP AG/ADR from a “sell” rating to a “hold” rating in a research report on Tuesday, September 11th.

LZAGY stock opened at $31.62 on Wednesday. The company has a market capitalization of $24.14 billion, a P/E ratio of 26.57, a P/E/G ratio of 2.17 and a beta of 1.02. LONZA GRP AG/ADR has a 1-year low of $22.74 and a 1-year high of $34.79.


Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide. The company operates through two segments, Pharma&Biotech and Specialty Ingredients. It offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to dosage forms for the pharma and consumer health, and nutrition industries, as well as develops cell and gene therapies.

Featured Story: SEC Filing

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for LONZA GRP AG/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LONZA GRP AG/ADR and related companies with MarketBeat.com's FREE daily email newsletter.